Hospital
Public Hospital District No. 2, Klickitat County, Washington
Public Hospital District No. 2, Klickitat County, Washington was paid $6.65M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.
33Billing provider infoPUBLIC HOSPITAL DISTRICT NO. 2, KLICKITAT COUNTY, WASHINGTON
WHITE SALMON, WA 98672
WHITE SALMON, WA 98672
33aNPI1760455687assigned 02/10/2006
33bProvider typeCritical Access Hospital
28Total paid$6.65M
24GClaims80,381
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Washington
Rank by total paid#19 of 30
Median peer was paid$9.10M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,750 | $530K | |
| 2019 | 11,462 | $674K | |
| 2020 | 9,524 | $717K | |
| 2021 | 12,662 | $1.02M | |
| 2022 | 15,119 | $1.66M | |
| 2023 | 12,872 | $1.24M | |
| 2024incomplete | 9,992 | $823K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 3,642 | 2,798 | $1.17M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 4,931 | 3,872 | $1.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,778 | 1,309 | $736K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.6% | 7,085 | 2,905 | $573K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4.5% | 4,807 | 1,995 | $299K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.0% | 1,760 | 1,452 | $268K |
| 80053 | Comprehensive metabolic panel | 3.4% | 4,590 | 3,889 | $223K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 233 | 176 | $213K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.3% | 816 | 748 | $154K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,102 | 982 | $146K |
| 87631 | 2.0% | 805 | 735 | $133K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 1,403 | 1,186 | $122K |
58 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 3,095 | $105K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 1,151 | $98K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 1,170 | $92K |
| J3490 | Unclassified drugs | 1.3% | 1,474 | $85K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 561 | $85K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,241 | $83K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 6,470 | $73K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 828 | $55K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,574 | $54K |
| 85027 | <1% | 1,997 | $53K | |
| 84484 | <1% | 1,247 | $51K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 980 | $50K |
| 83605 | <1% | 1,134 | $49K | |
| 71045 | Radiologic examination, chest; single view | <1% | 793 | $48K |
| 83690 | <1% | 1,494 | $46K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,232 | $45K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 693 | $43K |
| 97161 | <1% | 425 | $41K | |
| 80306 | <1% | 656 | $39K | |
| 83735 | <1% | 1,452 | $39K | |
| 84703 | <1% | 847 | $37K | |
| 85007 | <1% | 2,038 | $31K | |
| 83880 | <1% | 231 | $28K | |
| J2704 | Injection, propofol, 10 mg | <1% | 232 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 68 | $18K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 356 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 189 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 38 | $17K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 314 | $16K |
| A9270 | Non-covered item or service | <1% | 8,451 | $15K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 529 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 365 | $14K |
| 81001 | <1% | 1,269 | $13K | |
| 97162 | <1% | 92 | $12K | |
| 80061 | Lipid panel | <1% | 118 | $10K |
| 81003 | <1% | 1,051 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 257 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 259 | $7K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 182 | $5K |
| 84439 | <1% | 107 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 68 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 15 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 30 | $3K |
| 73630 | <1% | 29 | $3K | |
| 82550 | <1% | 128 | $2K | |
| 72100 | <1% | 13 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $2K |
| 94664 | <1% | 29 | $2K | |
| 73610 | <1% | 20 | $2K | |
| 73030 | <1% | 16 | $2K | |
| 85610 | <1% | 101 | $2K | |
| 82553 | <1% | 61 | $1K | |
| 85378 | <1% | 30 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 13 | $375.37 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $331.95 |
| 90686 | <1% | 26 | $277.33 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 27 | $8.20 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 139 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKIMMES, ROBERT (CEO)
| Provider | Location | Paid |
|---|---|---|
| Public Hospital District No 2, Klickitat County Washington | White Salmon, WA | $236K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.